IDiyas

For the Inventor, By the Inventor

Seoul, South Korea

Eui-Hwan Cho

USPTO Granted Patents = 11


 

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Kyungki-do, KR (2006)
  • Seoul, KR (1998 - 2021)

Company Filing History:

goldMedal9 out of 13 
 
Samjin Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 1 
 
Samjin Pharmaceuticazl Co., Ltd.
 patent
bronzeMedal1 out of 1 
 
Korea Research Inst. of Chem. Tech.
 patent
4. 1 out of 2 
 
Samjin Pharm. Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1998-2021

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 10918725 - Ophthalmic composition comprising rebamipide and method for preparing the same (2021-02-16),
2. 7851479 - Use of pyrimidinedione derivative for preventing or treating hepatitis C (2010-12-14),
3. 7230105 - 9-aminoacridine derivatives and process for the preparation thereof (2007-06-12),
4. 6987114 - Antiviral pyrimidinedione derivatives and process for the preparation thereof (2006-01-17),
5. 6683184 - Piperazine derivatives and process for the preparation thereof (2004-01-27),
6. 6620936 - 9-aminoacridine derivatives and process for the preparation thereof (2003-09-16),
7. 6274732 - Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione (2001-08-14),
8. 6136815 - Antiviral 2,4-pyrimidinedione derivatives and process for the (2000-10-24),
9. 6028195 - Piperazine derivatives and process for the preparation thereof (2000-02-22),
10. 5922727 - Antiviral substituted pyrimidinedione homocarbocyclic nucleoside (1999-07-13),
11. 5780472 - Piperazine derivatives and methods for the preparation thereof and (1998-07-14),

Title: Eui-Hwan Cho: Innovator in Ophthalmic and Pharmaceutical Solutions

Introduction

Eui-Hwan Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of ophthalmology and pharmaceuticals, holding a total of 11 patents. His innovative work focuses on developing compositions and methods that address critical health issues.

Latest Patents

One of his latest patents is an ophthalmic composition comprising rebamipide and a method for preparing the same. This composition maintains its transparency for an extended period, even in a physiologically neutral to weakly basic pH range, ensuring it does not injure the cornea and conjunctiva of patients suffering from dry eye. Additionally, it boasts improved stability, preventing re-dispersion. Another notable patent involves the use of a pyrimidinedione derivative for preventing or treating hepatitis C. This derivative exhibits excellent inhibitory activity against the hepatitis C virus, showcasing Cho's commitment to addressing significant health challenges.

Career Highlights

Eui-Hwan Cho has worked with reputable companies, including Samjin Pharmaceutical Co., Ltd. and Samjin Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical industry.

Collaborations

Throughout his career, Cho has collaborated with notable professionals, including Sun-Gan Chung and Ho-Seok Kwon. These partnerships have further enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Eui-Hwan Cho's contributions to ophthalmic and pharmaceutical innovations demonstrate his dedication to improving patient care and health outcomes. His patents reflect a deep understanding of medical needs and a commitment to developing effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…